by James Radke | Apr 19, 2021
Derralynn Hughes, MD, DPhil, FDCP, FRCPath, Professor of Experimental Haematology University College London and Clinical Director of Research and Innovation, Royal Free London NHS Foundation Trust, talks about her new CME program highlighting the latest...
by James Radke | Apr 19, 2021
This Tuesday, April 20th, join Ozlem Goker-Alpan MD, Founder and President of the Lysosomal & Rare Disorders Research & Treatment Center (LDRTC), and special guest Ari Zimran, MD, of the Shaare Zedek Medical Center, in a live CME/CE program discussing...
by James Radke | Apr 16, 2021
Shruti Chaturvedi, MBBS, MS, Assistant Professor of Medicine at Johns Hopkins lists two important things a clinician should monitor while treating a patient with thrombotic thrombocytopenic purpura (TTP). TTP is an ultra-rare hematologic condition that can...
by James Radke | Apr 15, 2021
Susan Samson, MD, PhD, of the Mayo Clinic in Jacksonville, FL, talks about the latest long term data presented at ENDO 2021 testing oral octreotide in people with acromegaly. In a 48-week open label extension of the CHIASMA OPTIMAL study, patients with...
by James Radke | Apr 12, 2021
Shruti Chaturvedi, MBBS, MS, from Johns Hopkins and X. Long Zheng, MD, PhD, from the University of Kansas Medical Center, discuss how to manage thrombotic thrombocytopenic purpura (TTP) during pregnancy. TTP is a rare hematologic condition that...
